MyD88: a Central Player in Innate Immune Signaling

Overview

Journal F1000Prime Rep

Specialty Biomedical Engineering

Date 2015 Jan 13

PMID 25580251

Citations 299

Authors

Jacques Deguine

Gregory M Barton

Affiliations

Soon will be listed here.

Abstract

MyD88 is the canonical adaptor for inflammatory signaling pathways downstream of members of the Toll-like receptor (TLR) and interleukin-1 (IL-1) receptor families. MyD88 links IL-1 receptor (IL-1R) or TLR family members to IL-1R-associated kinase (IRAK) family kinases via homotypic protein-protein interaction. Activation of IRAK family kinases leads to a variety of functional outputs, including the activation of nuclear factor-kappa B (NFκB), mitogen-activated protein kinases, and activator protein 1, making MyD88 a central node of inflammatory pathways. As more details of MyD88-dependent signaling have been elucidated, it has become clear that the functions of this critical signaling component can be influenced by multiple interaction partners in distinct subcellular compartments. In this review, we will focus on recent developments in the understanding of the assembly of MyD88 signaling complexes and the mechanisms leading to the diversification of MyD88-based signaling.

Citing Articles

Molecular Mechanisms in the Transformation from Indolent to Aggressive B Cell Malignancies.

Maher N, Mouhssine S, Matti B, Alwan A, Gaidano G Cancers (Basel). 2025; 17(5).

PMID: 40075754 PMC: 11899122. DOI: 10.3390/cancers17050907.

Myeloid Differentiation Primary Response Protein 88: An Important Therapeutic Target for Chronic Pain.

Liang H, Fu L, Li Z, Liu Z J Pain Res. 2025; 18:1061-1069.

PMID: 40061432 PMC: 11890100. DOI: 10.2147/JPR.S487685.

Osteopontin in Alzheimer's Disease: A Double-Edged Sword in Neurodegeneration and Neuroprotection-A Systematic Review.

Azizan Z, Bazrgar M, Bazgir N, Moini S, Ghaseminejad-Kermani S, Safa K CNS Neurosci Ther. 2025; 31(2):e70269.

PMID: 39957678 PMC: 11831194. DOI: 10.1111/cns.70269.

Atherosclerosis: A Comprehensive Review of Molecular Factors and Mechanisms.

Tasouli-Drakou V, Ogurek I, Shaikh T, Ringor M, DiCaro M, Lei K Int J Mol Sci. 2025; 26(3).

PMID: 39941130 PMC: 11818631. DOI: 10.3390/ijms26031364.

Fucoidan alleviated colitis aggravated by fiber deficiency through protecting the gut barrier, suppressing the MAPK/NF-κB pathway, and modulating gut microbiota and metabolites.

Zheng W, Tang S, Ren X, Song S, Ai C Front Nutr. 2025; 11:1462584.

PMID: 39925971 PMC: 11802440. DOI: 10.3389/fnut.2024.1462584.

References

Park H, Logette E, Raunser S, Cuenin S, Walz T, Tschopp J . Death domain assembly mechanism revealed by crystal structure of the oligomeric PIDDosome core complex. Cell. 2007; 128(3):533-46. PMC: 2908332. DOI: 10.1016/j.cell.2007.01.019. View

Gay N, Keith F . Drosophila Toll and IL-1 receptor. Nature. 1991; 351(6325):355-6. DOI: 10.1038/351355b0. View

Hacker H, Tseng P, Karin M . Expanding TRAF function: TRAF3 as a tri-faced immune regulator. Nat Rev Immunol. 2011; 11(7):457-68. DOI: 10.1038/nri2998. View

Janssens S, Burns K, Vercammen E, Tschopp J, Beyaert R . MyD88S, a splice variant of MyD88, differentially modulates NF-kappaB- and AP-1-dependent gene expression. FEBS Lett. 2003; 548(1-3):103-7. DOI: 10.1016/s0014-5793(03)00747-6. View

Kagan J, Su T, Horng T, Chow A, Akira S, Medzhitov R . TRAM couples endocytosis of Toll-like receptor 4 to the induction of interferon-beta. Nat Immunol. 2008; 9(4):361-8. PMC: 4112825. DOI: 10.1038/ni1569. View

Swann J, Vesely M, Silva A, Sharkey J, Akira S, Schreiber R . Demonstration of inflammation-induced cancer and cancer immunoediting during primary tumorigenesis. Proc Natl Acad Sci U S A. 2008; 105(2):652-6. PMC: 2206591. DOI: 10.1073/pnas.0708594105. View

Horng T, Barton G, Flavell R, Medzhitov R . The adaptor molecule TIRAP provides signalling specificity for Toll-like receptors. Nature. 2002; 420(6913):329-33. DOI: 10.1038/nature01180. View

Schneider D, Hudson K, Lin T, Anderson K . Dominant and recessive mutations define functional domains of Toll, a transmembrane protein required for dorsal-ventral polarity in the Drosophila embryo. Genes Dev. 1991; 5(5):797-807. DOI: 10.1101/gad.5.5.797. View

Oda K, Kitano H . A comprehensive map of the toll-like receptor signaling network. Mol Syst Biol. 2006; 2:2006.0015. PMC: 1681489. DOI: 10.1038/msb4100057. View

10.

Yamamoto M, Sato S, Hemmi H, Hoshino K, Kaisho T, Sanjo H . Role of adaptor TRIF in the MyD88-independent toll-like receptor signaling pathway. Science. 2003; 301(5633):640-3. DOI: 10.1126/science.1087262. View

11.

Burns K, Martinon F, Esslinger C, Pahl H, Schneider P, Bodmer J . MyD88, an adapter protein involved in interleukin-1 signaling. J Biol Chem. 1998; 273(20):12203-9. DOI: 10.1074/jbc.273.20.12203. View

12.

Wesche H, Henzel W, Shillinglaw W, Li S, Cao Z . Pillars article: MyD88: an adapter that recruits IRAK to the IL-1 receptor complex. Immunity. 1997. 7: 837-847. J Immunol. 2012; 190(1):5-15. View

13.

Jin M, Kim S, Heo J, Lee M, Kim H, Paik S . Crystal structure of the TLR1-TLR2 heterodimer induced by binding of a tri-acylated lipopeptide. Cell. 2007; 130(6):1071-82. DOI: 10.1016/j.cell.2007.09.008. View

14.

Hultmark D . Macrophage differentiation marker MyD88 is a member of the Toll/IL-1 receptor family. Biochem Biophys Res Commun. 1994; 199(1):144-6. DOI: 10.1006/bbrc.1994.1206. View

15.

Lee B, Barton G . Trafficking of endosomal Toll-like receptors. Trends Cell Biol. 2014; 24(6):360-9. PMC: 4037363. DOI: 10.1016/j.tcb.2013.12.002. View

16.

Means T, Latz E, Hayashi F, Murali M, Golenbock D, Luster A . Human lupus autoantibody-DNA complexes activate DCs through cooperation of CD32 and TLR9. J Clin Invest. 2005; 115(2):407-17. PMC: 544604. DOI: 10.1172/JCI23025. View

17.

Honda K, Yanai H, Mizutani T, Negishi H, Shimada N, Suzuki N . Role of a transductional-transcriptional processor complex involving MyD88 and IRF-7 in Toll-like receptor signaling. Proc Natl Acad Sci U S A. 2004; 101(43):15416-21. PMC: 523464. DOI: 10.1073/pnas.0406933101. View

18.

Krieg A . CpG motifs in bacterial DNA and their immune effects. Annu Rev Immunol. 2002; 20:709-60. DOI: 10.1146/annurev.immunol.20.100301.064842. View

19.

Burns K, Janssens S, Brissoni B, Olivos N, Beyaert R, Tschopp J . Inhibition of interleukin 1 receptor/Toll-like receptor signaling through the alternatively spliced, short form of MyD88 is due to its failure to recruit IRAK-4. J Exp Med. 2003; 197(2):263-8. PMC: 2193806. DOI: 10.1084/jem.20021790. View

20.

Wang L, Yang J, Kabaleeswaran V, Rice A, Cruz A, Park A . The Fas-FADD death domain complex structure reveals the basis of DISC assembly and disease mutations. Nat Struct Mol Biol. 2010; 17(11):1324-9. PMC: 2988912. DOI: 10.1038/nsmb.1920. View